This was the stock's second consecutive day of losses.

Charles River Laboratories International Inc. closed 46.74% short of its 52-week high of $264.71, which the company reached ...

Charles River Watershed Association (CRWA) has elected Paul Levy as the president of the nonprofit’s board of directors at its annual meeting last Wednesday.

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to discover new molecules and potential therapies. Pfizer is partnering with ...

Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

S&P 500 and Nasdaq hit their six-month low level on Monday as investors’ concerns rise over the upcoming Donald Trump’s ...

The global US Biomarkers Market is expected to reach US$34.3 billion by 2029 from US$20.5 billion in 2024, at a CAGR of 10.8% during ...

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned an average rating of ...

Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...